We're looking for people who have experienced psychosis and are currently taking oral antipsychotic medication. This study explores whether a treatment called transcranial direct current stimulation or tDCS, can improve people's understanding of their unique experiences. For this treatment, a non-invasive cap is worn to deliver a low electrical pulse to a specific area of your brain. It's safe, effective and is commonly used to treat depression. This study will take place over 3-4 months.
Eligibility Criteria
- Age range: 18 years or older
- Fluent in English
- Have schizophrenia or schizoaffective disorder
- Taking oral antipsychotic medication
- Gender: All
- Ethnicity: All
What does the study involve?
Number of contacts: 10+ in-person visits
Compensation offered? Yes
Investigator(s): Dr. Philip Gerretsen
Contact Information:
E-mail: mmigresearch@camh.ca
REB number: 103/2018
REB Approval Expiry Date: October 21, 2025
PLEASE NOTE:
- Research staff cannot give medical advice over the phone or via email.
- If you have specific questions regarding your health care, please contact your family physician.
- We regret that not everyone screened for a study will be eligible to participate
- For more information about other treatment options for mental illness or addiction offered by CAMH, visit www.camh.ca or call 416-535-8501.